Education
About Us
Working with TipRanks
Follow Us
Jeffrey W. Sherman Insider Profile
4 Followers
Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics, holds 169.78K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 64.26K shares in Strongbridge Biopharma (Ticker: SBBP).
Jeffrey W. Sherman Horizon Therapeutics (HZNP)EVP and Chief Medical Officer
Horizon Therapeutics (HZNP)
EVP and Chief Medical Officer
Ranked #37,500 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+27.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey W. Sherman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 29, 2023 - Nov 29, 2024
Return:+77.70%
The most profitable trade made by Jeffrey W. Sherman
Jeffrey W. Sherman's Trading History
Horizon Therapeutics
Oct 06, 2023
―
Uninformative Sell
27.35M
$0.00
Strongbridge Biopharma
Oct 05, 2021
―
Uninformative Sell
36.59K
$128.52K
Xeris Pharmaceuticals
Jun 05, 2024
Director
Uninformative Buy
―
$719.87K
Larimar Therapeutics
―
Director
―
―
Insys Therapeutics
―
―
―
$137.80
List of latest transactions for each holding click on a transaction to see Jeffrey W. Sherman's performance on stock
You May Also Like
Jeffrey W. Sherman insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey W. Sherman?
The percentage of profitable transactions made by Jeffrey W. Sherman is 50%.
What is the average return per transaction made by Jeffrey W. Sherman?
The average return per transaction made by Jeffrey W. Sherman is 27.70%.
What stocks does Jeffrey W. Sherman hold?
Jeffrey W. Sherman holds: HZNP, SBBP, XERS, LRMR, INSYQ stocks.
What was Jeffrey W. Sherman’s latest transaction?
Jeffrey W. Sherman latest transaction was an Uninformative Buy of ―.
What was Jeffrey W. Sherman's most profitable transaction?
Jeffrey W. Sherman’s most profitable transaction was an Informative Buy of XERS stock on November 29, 2023. The return on the trade was 77.70%.
What is Jeffrey W. Sherman's role in Horizon Therapeutics?
Jeffrey W. Sherman's role in Horizon Therapeutics is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.